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Aim To compare the frequency of alleles and genotypes 
in brain-derived neurotrophic factor (BDNF) val66met poly-
morphism in ethnically homogenous Caucasian (from Cro-
atia) and ethnically homogenous Asian (from South Ko-
rea) healthy participants, as inter-population differences in 
BDNF val66met may be responsible for the divergent find-
ings in genetic and association studies.
Methods BDNF val66met was genotyped in 800 (556 Croa-
tian and 244 Korean) healthy participants. Frequencies of 
alleles and genotypes were evaluated using a χ2 test.
Results The frequencies for genotypes (χ22 = 114.69; 
P < 0.001) and alleles (χ21 = 120.07; P < 0.001) between Ko-
rean and Croatian individuals differed significantly, due to 
significantly lower (46.3% and 19.5%, P < 0.001) frequency 
of “Met” allele and significantly higher (53.7% and 80.5%, 
P < 0.001) frequency of “Val” allele in Croatian than in Ko-
rean participants.
Conclusion The study found significant ethnic differences 
in BDNF val66met polymorphism. The most frequent gen-
otype among Korean participants was “Met/Val” and they 
had similar distribution of “Met” and “Val” alleles. In con-
trast, the most frequent genotype among Caucasian par-
ticipants was “Val/Val” and they had different distribution 
of “Met” and “Val” alleles. These ethnic differences require 
matching participants for ethnicity in pharmacogenetic 
studies and in the studies investigating genetic variations 
in neuropsychiatric disorders.
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Brain-derived neurotrophic factor (BDNF) is a member of 
neurotrophin family of growth factors (1). BDNF is locat-
ed in the hippocampus, neocortex, amygdala, cerebellum, 
and hypothalamus, and it regulates memory formation 
and processing, learning, locomotion, food intake, noci-
ception, mood, cognition, behavior, and stress response 
(1). It affects cholinergic, dopaminergic, and serotonergic 
neurotransmitter systems, which are altered in many neu-
rodegenerative and psychiatric disorders (2). BDNF modu-
lates neural proliferation, survival, repair, neurodegenera-
tion (reductions in hippocampal neuronal plasticity and 
resiliency), and is associated with Alzheimer disease, major 
depression, posttraumatic stress disorder, schizophrenia, 
and bipolar affective disorder (1).
A single nucleotide polymorphism (SNP) of the BDNF gene 
(val66met) exists in the 5′ prodomain region of the BDNF 
gene. This polymorphism includes the substitution of va-
line (“Val”) into methionine (“Met”) in codon 66 (BDNF val-
66met). Although this polymorphism does not affect the 
structure of the mature BDNF protein (3), the mechanism 
by which this polymorphism initiates the changes in hu-
man memory and hippocampal function is related to alter-
ations in intracellular trafficking and secretion of BDNF (4). 
BDNF val66met is a functional polymorphism (G196A, NCBI 
database dbSNP rs6265), reported to be associated with 
alterations in hippocampal volume, emotional reactivity, 
and anxiety and depression-related personality traits (5). 
It is also related to poorer episodic memory performance, 
lower depolarization-induced production of BDNF, lower 
hippocampal measure of neuronal integrity and synaptic 
abundance, n-acetyl asparatate content, and lower lev-
els of hippocampal activation during memory processing 
(3,6-8).
There are divergent findings of the positive or negative 
associations between BDNF val66met polymorphism and 
schizophrenia, unipolar depression and bipolar disorder, 
eating disorders, alcoholism, substance abuse, and anxiety 
and depression-related personality traits in Caucasian and 
Asian participants (2). These differences might be induced 
by ethnic differences in Caucasian and Asian participants 
(2,6,8-12). However, the cited studies frequently included 
psychiatric patients and healthy participants, who were 
not homogenous within the particular ethnic groups. The 
hypothesis of our study was that BDNF val66met polymor-
phism differed between ethnically homogenous Cauca-
sian and ethnically homogenous Asian healthy individu-
als. The aim of the study was to compare the frequency 
of “Met/Met,” “Met/Val,” and “Val/Val” genotypes and 
“Met” and “Val” alleles in healthy male and female partici-




This comparative study included 800 unrelated healthy vol-
unteers from two centers: 556 Caucasian healthy partici-
pants of Croatian origin from Zagreb, Croatia (349 men and 
207 women; mean age (± standard deviation) 33.8 ± 9.05 
years) and 244 Asian healthy participants of Korean origin 
from Seoul, South Korea (129 men and 115 women; mean 
age 32.5 ± 8.4 years). Caucasian participants were recruit-
ed from October 2001 to March 2006 from the University 
Hospital Dubrava, Zagreb, Croatia. Asian participants were 
recruited from May 2000 to October 2005 from the Asan 
Medical Center, University of Ulsan College of Medicine, 
Seoul, South Korea. Inclusion criteria were not taking med-
ications; no previous or current psychiatric disorders; no al-
cohol abuse or suicidal attempts; no family history of psy-
chiatric disorders (this was determined according to the 
answers of participants about the mental health status of 
their parents, grandparents, and close relatives); not being 
mutually related; and belonging to the native ethnic group 
of the regions studied. Written informed consent was ob-
tained from all participants, after the aims and procedures 
of the study had been explained. The study was performed 
in accordance with the ethical standards of the Declaration 
of Helsinki and approved by the Ethics Committees of the 
University Hospital Dubrava, Zagreb, Croatia or Asan Medi-
cal Center, University of Ulsan College of Medicine, Seoul, 
South Korea.
Genotyping of BDNF Val/Met
Genomic DNA was isolated from peripheral blood leuko-
cytes according to standard procedures of proteinase-K-
RNase digestion followed by phenol-chloroform extrac-
tion in Korean participants (13) or by a salting out method 
in Croatian participants (14). In Korean participants, BDNF 
val66met polymorphism (rs6265) was genotyped using a 
single-base primer extension assay (ABI PRISM SNaPshot 
Multiplex kit; ABI, Foster City, CA, USA) according to the 
manufacturer’s recommendations. Genomic DNA flanking 
the SNP (rs6265) was amplified by polymerase chain reac-
tion (PCR) using the primers: 5’-TGATGACCATCCTTTTCCTT-
3’ (forward) and 5’-CACTGGGAGTTCCAATGC-3’ (reverse); 
each PCR reaction utilized 10 ng genomic DNA, 0.5 pM of 
each oligonucleotide primer, 1 µL 10X PCR Gold buffer, 250 
μM dNTP, 3 mM MgCl2, and 0.25 unit i-StarTaq DNA Poly-
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merase (iNtRON Biotechnology, Sungnam, Kyungki-Do, Ko-
rea) in a total reaction volume of 10 µL. The amplification 
protocol consisted of one cycle of denaturation at 95°C 
for 10 minutes, 30 cycles of initial denaturation at 95°C for 
30 seconds, annealing at 55°C for 1 minute, and extension 
at 72°C for 1 minute, followed by a final extension at 72°C 
for 7 minutes. The PCR products were treated with 1 unit 
of shrimp alkaline phosphatase (SAP) (Roche, Mannheim, 
Germany) and 1 unit of exonuclease I (USB Corporation, 
Cleveland, OH, USA) for 60 minutes at 37°C followed by 15 
minutes at 72°C to purify the amplified products. A 1 µL 
aliquot of each purified amplification product was added 
to a SNaPshot Multiplex Ready reaction mixture containing 
0.15 pmol genotyping primer for the primer extension re-
action, which consisted of 25 cycles at 96°C for 10 seconds, 
50°C for 5 seconds, and 60°C for 30 seconds. These reac-
tion products were treated with 1 unit of SAP for 1 hour 
at 37°C, followed by 15 minutes at 72°C to remove excess 
fluorescent dye terminators. A 1 µL aliquot of each sample 
was added to 9 µL of Hi-Di formamide (ABI) and incubated 
at 95°C for 5 minutes, followed by 5 minutes on ice. The re-
action products were analyzed by electrophoresis using an 
ABI Prism 3730xl DNA analyzer, with the results interpreted 
using GeneScan analysis software (ABI).
In Croatian participants, BDNF val66met polymorphisms 
was genotyped in ABI Prism 7000 Sequencing Detection 
System apparatus (ABI) using Taqman-based allele-specific 
polymerase chain reaction assay, according to the proce-
dure described by the Applied Biosystems (Applied Biosys-
tems, Foster City, CA, USA). The primers and probes were 
purchased from Applied Biosystems.
Statistical analysis
The genotype frequency was assessed for Hardy-Weinberg 
equilibrium with a χ2 test. Statistical differences in geno-
type and allele frequencies between Korean and Croatian 
healthy participants were evaluated by a χ2 test. Age of the 
participants (expressed in years as means ± standard de-
viation) was evaluated using one-way analysis of variance 
(ANOVA). Bonferroni correction was used for multiple test-
ing, using the total number of pair comparison of ethnic 
groups (N = 2) as a correction factor and the level of sig-
nificance was set to α = 0.025. All statistical analyses were 
performed with SigmaStat 3.1 (Jandell Scientific Corp., San 
Raphael, CA, USA).
reSultS
South Korean (age 32.5 ± 8.4 years) and Croatian (age 
33.8 ± 9.05 years) participants were matched for age and 
one way ANOVA showed no significant differences in age 
(F = 2.73; df = 1623; P = 0.099).
Genotype and allele frequencies of the BDNF val66met 
polymorphism were determined in 800 healthy partici-
pants: 556 Croatian participants and 244 Korean par-
ticipants (Table 1). The observed genotype distribution 
in Korean (χ21 = 1.444; P = 0.229) or Croatian (χ
2
1 = 0.406; 
P = 0.524) samples did not differ significantly from the ex-
pected Hardy-Weinberg equilibrium. In Koreans, the gen-
otype frequency “Met/Met” was found in 57 participants 
(23.4%), “Met/Val” in 112 participants (45.9%), and “Val/
Val” in 75 participants (30.7%). In Croatians, “Met/Met” was 
found in only 19 participants (3.4%), “Met/Val” in 180 par-
ticipants (32.4%), and “Val/Val” in 357 participants (64.2%). 
There were significant differences in the frequency of “Met/
Met,” “Met/Val,” and “Val/Val” genotypes between all Korean 
and Croatian participants (χ22 = 114.68; P < 0.001), between 
male Korean and male Croatian participants (χ22 = 65.25; 
P < 0.001), and between female Korean and female Croa-
tian participants (χ22 = 49.06; P < 0.001). The most frequent 
genotype among Korean participants (either in both sexes, 
or separately in men or women) was “Met/Val,” while the 
most frequent genotype among Croatian participants (ei-
ther in both sexes, or separately in men or women) was 
taBle 1. Genotype and allele frequencies of the brain-derived neurotrophic factor val66met polymorphism in asian 
(Korean) and caucasian (croatian) participants
Genotype (No, %) allele (No, %)
Participants aa (Met/Met) aG (Met/Val) GG (Val/Val) a (Met) G (Val)
Korean (n = 244): 57 (23.4) 112 (45.9) 75 (30.7) 226 (46.3) 262 (53.7)
male (n = 129) 25 (19.4)  68 (52.7) 36 (27.9) 118 (45.7) 140 (54.3)
female (n = 115) 32 (27.8)  44 (38.3) 39 (33.9) 108 (47.0) 122 (53.0)
croatian (n = 556): 19 (3.4) 180 (32.4) 357 (64.2) 217 (19.5) 894 (80.5)
male (n = 349) 12 (3.4) 111 (31.8) 226 (64.8) 135 (19.3) 563 (80.7)
female (n = 207)  7 (3.4)  69 (33.3) 131 (63.3) 82 (19.9) 331 (80.1)
*abbreviations: Met – methionine; Val – valine.
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“Val/Val.” To control for the possible sex-related differenc-
es in the BDNF val66met polymorphism within the particu-
lar ethnic group, BDNF val66met was compared separately 
in male and female Korean or male and female Croatian 
participants. No significant differences in the occurrence 
of “Met/Met,” “Met/Val,” and “Val/Val” genotypes were found 
for Korean (χ22 = 5.34; P = 0.069) or Croatian (χ
2
2 = 0.139; 
P = 0.933) men and women (Table 1).
The frequency of the “Met” and “Val” alleles was signifi-
cantly different (Table 1) in Asian and Croatian partici-
pants (χ21 = 120.07; P < 0.001), Korean and Croatian men 
(χ21 = 66.09; P < 0.001), and Korean and Croatian women 
(χ21 = 51.64; P < 0.001). All Korean participants, Korean men, 
and Korean women had similar distribution of “Met” and 
“Val” alleles (46.3%, 45.7%, and 47.0% and 53.7%, 54.3%, 
and 53.0%, respectively). All Croatian participants, Croa-
tian men, and Croatian women had significantly (P < 0.001) 
lower frequency of “Met” allele (19.5%, 9.3% and 19.9%) 
and significantly (P < 0.001) higher frequency of “Val” allele 
(80.5%, 80.7%, and 80.1%) than Korean participants. No sig-
nificant differences were detected in the allele frequency 
between male and female Korean (χ21 = 0.03; P = 0.858) or 
between male and female Croatian (χ21 = 0.02; P = 0.896) 
participants (Table 1).
DiScuSSioN
Our comparative multi-centric study demonstrated signifi-
cant ethnic differences in the frequency of the BDNF val-
66met alleles and genotypes in healthy male and female par-
ticipants recruited from ethnically homogenous Caucasian 
(of Croatian origin) and Asian participants (of Korean origin). 
Besides a meta-analysis of the case-control studies (2) and a 
comparison of the data with the previous reports (11), this 
is the first direct comparison of the frequencies of the BDNF 
val66met alleles and genotypes in large groups of Caucasian 
and Asian healthy participants. In line with previous find-
ings (2,6,8-12), our results showed the opposite genotype 
frequencies in the two ethnic populations: the “Met/Val” 
genotype was most frequent in Asian participants, while 
“Val/Val” genotype was most frequent in Caucasian partic-
ipants. In our study, the distribution of the “Met” and “Val” 
alleles was almost equal in Asian population, a result con-
firmed by the reported frequency of 43-58% (15) or 45.9-
41.7% (2) for “Met” allele in different Asian populations. On 
the other hand, the majority of our Caucasian individuals 
were carriers of the “Val” allele. This finding agrees with the 
reported frequency of 84-78% (15) or 80.1-81.5% (2) for 
“Val” allele in various Caucasian populations.
Ethnic differences between Asian or Caucasian participants 
in our study were not due to different sex of the partici-
pants, which is in agreement with previous data on BDNF 
(2,9,16,17). Absence of sex-related differences was also re-
ported for BDNF concentration in serum or plasma (18-20)
Ethnic differences in BDNF val66met might be associated 
with smoking status (9) and different anxiety-like person-
ality traits (17). It has been reported that Caucasian partici-
pants (of German origin), carriers of the “Met” alleles, were 
more vulnerable to initiate and/or maintain smoking (9). 
Since Croatian (Caucasian) and Korean (Asian) healthy in-
dividuals were not controlled for smoking habits or anxi-
ety-like personality traits, the possible association of smok-
ing and/or anxiety-like personality traits and BDNF val66met 
cannot be excluded.
BDNF regulates food intake, eating behavior, and energy 
expenditure (1). In healthy Caucasian individuals, “Met/
Met” genotype was connected with the lower body mass 
index (BMI) (21). Hence, ethnic differences in BDNF val-
66met might be associated with different BMI, dietary hab-
its, and obesity status in Croatian (Caucasian) and Korean 
(Asian) participants. Epidemiological data (22,23) suggest 
that Croatian participants are overweight or obese, while 
Koreans still have lower BMI than most of the examinees 
in the Western countries (24). Although we did not de-
termine BMI, eating patterns, caloric intake, daily exercise, 
and physical activity in our Caucasian and Asian groups, 
we might presume that these and other unknown factors 
might have accounted for the ethnic differences in BDNF 
val66met in Asian compared with Caucasian healthy indi-
viduals.
Significant ethnic differences in the BDNF val66met poly-
morphism may arise from a natural selection of a particular 
allele or from the influence of various environmental fac-
tors, or might be induced by a fixation of allele frequency 
through a founder effect (2). These differences, other ge-
netic and environmental factors, and factors like popula-
tion stratification, inadequate sample sizes, different di-
agnostic instruments, may contribute to the divergent 
findings in pharmacogenetic studies, and in the studies 
investigating genetic variations in neuropsychiatric disor-
ders among different ethnic groups (2,4,15). Caucasian and 
Asian participants with homozygosity for the “Met” allele 
have an increased risk for schizophrenia and carriers of the 
“Val/Met” and the “Met/Met” genotypes have an increased 
risk for eating disorders, while Caucasian and Asian carri-
ers of “Val” allele have an increased risk for substance-re-
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lated disorders (2). Caucasian carriers with “Val/Val” geno-
type have higher anxiety scores than carriers of “Met/Met” 
or “Val/Met” genotype (17). These data suggest an involve-
ment of BDNF val66met polymorphism in the etiology of 
substance-related disorders, eating disorders, schizophre-
nia (2,15), anxiety related personality traits (17), and neu-
roticism (10).
The limitation of the study was that we did not control 
for the smoking status, anxiety-like personality traits, eat-
ing patterns, body mass index, caloric intake, daily exercise, 
and physical activity in our participants. The advantages 
of the study were its size and homogeneity, as well as the 
evaluation of BDNF val66met in all participants and sepa-
rately in men and women, and conservative Bonferroni 
correction used for multiple testing.
In conclusion, our study showed significant ethnic differ-
ences in the BDNF val66met polymorphism in Korean and 
Croatian healthy participants, with significantly lower fre-
quency of “Met” allele and significantly higher frequency 
of “Val” allele in Croatian than in Korean participants. Ethnic 
differences in BDNF val66met polymorphism found in the 
present and previous (2,11,15) studies, with other multiple 
genetic and environmental factors, might be responsible 
for the diversity of the reported positive and negative as-
sociations between this polymorphism and various neu-
ropsychiatric disorders. Our results suggest that a careful 
matching of the participants for ethnicity, among other 
factors, should be done in pharmacogenetic studies, or 
in the studies investigating complex molecular pathways 
involved in the pathogenesis of psychiatric and neurode-
generative disorders.
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